A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease.
In a new preclinical study, a Northwestern Medicine® scientist has isolated the motor neurons in the brain that die in ALS and, for the first time, dressed them in a green fluorescent jacket. As a result, scientists will now be able to track what goes wrong in these cells to cause their deaths and be able to search for effective treatments.
Alzheimer’s drug may act like bad electrician, messing up wiring in brain and nervous system.
New Role for Ancient Clock The pancreas has its own molecular clock. Now, for the…